ATC Group: R03AL05 Formoterol and aclidinium bromide

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of R03AL05 in the ATC hierarchy

Level Code Title
1 R Respiratory system
2 R03 Drugs for obstructive airway diseases
3 R03A Adrenergics, inhalants
4 R03AL Adrenergics in combination with anticholinergics
5 R03AL05 Formoterol and aclidinium bromide

Active ingredients in R03AL05

Active Ingredient Description
Formoterol and Aclidinium bromide

Aclidinium is a long-acting muscarinic antagonist (also known as an anticholinergic) and formoterol is a long-acting β2-adrenergic agonist. The combination of these substances with different mechanisms of action results in additive efficacy compared to that achieved with either component alone. Relaxation of both central and peripheral airways with combination treatment may contribute to the beneficial effects of aclidinium/formoterol combination on lung function.

Related product monographs

Title Information Source Document Type  
DUAKLIR GENUAIR Inhalation powder European Medicines Agency (EU) MPI, EU: SmPC

Medicines in this ATC group

United States (US)

Australia (AU)

Austria (AT)

Canada (CA)

Croatia (HR)

Estonia (EE)

Finland (FI)

Hong Kong (HK)

Ireland (IE)

Israel (IL)

Lithuania (LT)

Netherlands (NL)

New Zealand (NZ)

Poland (PL)

Romania (RO)

Singapore (SG)

Spain (ES)

Turkey (TR)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.